J Clin Oncol 2015 Nov 1
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Related Questions
Given OlympiA trial with olaparib benefit for gBRCA+ patients?What are barriers that you foresee? In your practice who performs mutation testing and w...
New comment by Medical Oncologist at Wind River Onc ( May 19, 2022)
It is true that different types of testing should be done when the breast cancer is discovered. I feel that as much knowledge as possible is necessary at the first opportunity...